Orally administered atogepant was efficacious, safe, and tolerable for the prevention of migraine: results from a phase 2b/3 study

被引：0
|
作者：
Goadsby, P. J. [1 ]
Dodick, D. W. [2 ]
Ailani, J. [3 ]
Trugman, J. M. [4 ]
Finnegan, M. [4 ]
Lakkis, H. [4 ]
Lu, K. [4 ]
Szegedi, A. [4 ]
机构：
[1] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[2] Mayo Clin, Phoenix, AZ USA
[3] Medstar Georgetown Univ Hosp, Washington, DC USA
[4] Allergan Plc, Madison, NJ USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO3117
引用
收藏
页码：811 / 811
页数：1
相关论文
共 50 条
  • [21] Levadex™, a novel orally inhaled treatment for acute migraine: efficacy and tolerability results of a phase 3 study
    Kori, S.
    Silberstein, S.
    Aurora, S.
    Tepper, S.
    Borland, S.
    Wang, M.
    Reppine, A.
    Armer, T.
    Dodick, D.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S115 - S115
  • [22] Global Endpoints in IBS Clinical Trials: Results from a Phase 2B Study of Linaclotide
    Johnston, Jeffrey M.
    MacDougall, James E.
    Lavins, Bernard J.
    Lembo, Anthony J.
    Schneier, Harvey
    Shiff, Steven J.
    Kurtz, Caroline B.
    Currie, Mark G.
    GASTROENTEROLOGY, 2009, 136 (05) : A45 - A46
  • [23] Setrusumab for the Treatment of Osteogenesis Imperfecta (OI): Results from the Phase 2b ASTEROID Study
    Glorieux, Francis
    Javaid, Muhammad K.
    Langdahl, Bente
    Chapurlat, Roland
    De Beur, Suzanne Jan
    Sutton, V. Reid
    Poole, Kenneth
    Orwoll, Eric S.
    Willie, Bettina
    Mikolajewicz, Nicholas
    Clancy, James
    MacKinnon, Alastair
    Mistry, Arun
    Ominsky, Michael S.
    Saville, Chris
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 5 - 6
  • [24] Ligelizumab for adolescent patients with CSU: first results from a dedicated Phase 2b study
    Ben-Shoshan, Moshe
    Sekerel, Bulent Enis
    Staubach-Renz, Petra
    Alvaro-Lozano, Montserrat
    Maurer, Marcus
    Drollmann, Anton
    Bienczak, Andrzej
    Porter, Miriam
    Liu, Tian
    Burciu, Alis
    Severin, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB179 - AB179
  • [25] Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials
    Silberstein, Stephen D.
    McAllister, Peter
    Ning, Xiaoping
    Faulhaber, Nicola
    Lang, Nicole
    Yeung, Paul
    Schiemann, Jimmy
    Aycardi, Ernesto
    Cohen, Joshua M.
    Janka, Lindsay
    Yang, Ronghua
    HEADACHE, 2019, 59 (06): : 880 - 890
  • [26] Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study
    Schreiber, S. W.
    Watanabe, M.
    Yun, C.
    Zhou, Y.
    Zhao, S.
    Hsieh, J.
    Moerch, U.
    Rogler, G.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S004 - S005
  • [27] SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY AND PHASE 3 SELECTIONLTE LONG-TERM EXTENSION STUDY
    Schreiber, Stefan
    Loftus, Edward V.
    Rogler, Gerhard
    Yun, Chohee
    Zhou, Yan
    Zhao, Sally
    Hsieh, Jeremy
    Moerch, Ulrik
    Watanabe, Mamoru
    GASTROENTEROLOGY, 2021, 160 (06) : S37 - S38
  • [28] Rimegepant is Safe and Tolerable for the Acute Treatment of Migraine in Patients Using Preventive Migraine Medications: Results from a Long-Term Open-Label Safety Study
    Schim, Jack
    Hutchinson, Susan
    Lipton, Richard
    Croop, Robert
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Lovegren, Meghan
    Coric, Vlad
    Jensen, Christopher
    NEUROLOGY, 2021, 96 (15)
  • [29] Rimegepant is Safe and Tolerable for the Acute Treatment of Migraine in Patients Using Preventive Migraine Medications: Results From a Long-term Open-Label Safety Study (Study 201)
    Hutchinson, S.
    Schim, J.
    Lipton, R. B.
    Croop, R.
    Stock, E. G.
    Thiry, A. C.
    Conway, C. M.
    Lovegren, M.
    Coric, V
    Jensen, C. M.
    HEADACHE, 2020, 60 : 122 - 123
  • [30] Effect of Linaclotide On Quality of Life in Adults with Chronic Constipation: Results from a Phase 2B Study
    Lavins, Bernard J.
    Johnston, Jeffrey M.
    MacDougall, James E.
    Lembo, Anthony J.
    Schneier, Harvey
    Shiff, Steven J.
    Carson, Robyn T.
    Kurtz, Caroline B.
    Currie, Mark G.
    GASTROENTEROLOGY, 2009, 136 (05) : A71 - A71
12345